EASL & ICE-HBV Joint Research Think Tank – Novel HBV therapy concepts: insights from experimental and clinical studies at ILC 2022
Fabien Zoulim, ICE-HBV & Tobias Böttler, EASL
- Immunological and virological biomarkers: what biomaterials should be sampled during clinical trials?
Sofia Pérez-Del-Pulgar, Spain
- Virological strategies to achieve functional cure
Barbara Testoni, France
- Immunological strategies to achieve functional cure
Mala Maini, United Kingdom
- Debate: Is inhibition of viral replication and antigen expression needed for immunotherapy to achieve functional cure?
An HBsAg view: Paola Fisicaro, Italy & An HBcrAg view: Markus Cornberg, Germany
The EASL 2022 will be organized from 22-26 June 2022, inviting more than thousands of delegates. This annual congress will be hosted by the European Association for the study of the liver (EASL), where the medical experts will meet and present the best ideas and innovative technology for better liver care and transplantation.
EASL 2022 will be in hybrid format (Onsite + Digital) where one can find more platforms for learning and networking. There will be session rooms, networking locations, catering, exhibition, poster area, and shared spaces for the members and delegates to meet, interact and discuss. You can attend the interactive sessions, great rounds, expert workshops, an extensive skills-learning path, etc which will be some highlights of the program set. All the submitted abstracts will also be presented at the EASL 2022 Annual congress. Topics like hepatocellular carcinoma (HCC), cholangiocarcinoma (CCA), and rare primary liver cancers will also be discussed during the congress.
The venue for the meet is Excel London.